Hypertrophy and Atrophy of the Heart: the Other Side of Remodeling.
From: University of Texas Houston Medical School, 6431 Fannin, MSB 1.246, Houston, TX 77030, USA.
Annals of the New York Academy of Sciences
- Publish Date: Oct 2006
- ISSN: 0077-8923
- Volume: 1080
- Issue:
- Pages: 110-9
- Medium: Print
- Language: English
- Citation (JAMA): Razeghi Peter, Taegtmeyer Heinrich, et al. Hypertrophy and Atrophy of the Heart: the Other Side of Remodeling.. Ann. N. Y. Acad. Sci. Oct 2006;1080:110-9
Abstract
The size of a cardiomyocyte is determined by relative rates of protein synthesis and degradation. Signaling pathways regulating myocardial protein synthesis have been extensively investigated, not the least because in patients hypertrophy increases cardiovascular morbidity and mortality. Until now strategies to reverse hypertrophy have relied on the inhibition of prohypertrophic signaling pathways. Here we review signaling pathways of atrophy in the heart and we present evidence in support of the idea that activating proatrophic signaling pathways in the presence of prohypertrophic signaling may be an attractive strategy to reverse hypertrophy.
Mesh Headings (Keywords): Animals, Heart, Humans, Hydrolysis, Muscle Proteins, Signal Transduction
Check for Full Text / PubMed Unique Identifier (PMID): 17132779
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.